Synergy Pharmaceuticals (SGYP) Underwriters Execrcise Over-Allotment in 10M Offering
Synergy Pharmaceuticals Inc. (Nasdaq: SGYP) announced the exercise of the remainder of the over-allotment option granted to the underwriters with respect to the purchase of 750,000 shares of common stock at a public offering price of $4.50 per share, in connection with its previously announced underwritten public offering of 10,000,000 shares of common stock, bringing total gross proceeds from the offering to $51,750,000.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synergy Pharma (SGYP) CFO to Resign
- Paragon Shipping (PRGN) Updates on Newbuilding Contracts, Debt Obligations; Files Suit Against Tradewinds
- After-Hours Stock Movers 04/27: (AEZS) (DLB) (FB) Higher; (OCN) (SGI) (OSIS) Lower (more...)
Create E-mail Alert Related CategoriesCorporate News, Equity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!